Донецький Національний Медичний Університет Ім. М. Горького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький Національний Медичний Університет Ім. М. ГорькогоfiledCriticalДонецький Національний Медичний Університет Ім. М. Горького
Priority to UAU201404815UpriorityCriticalpatent/UA94010U/en
Publication of UA94010UpublicationCriticalpatent/UA94010U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for treating adenomyosis in women by assigning a course of intramuscular and subcutaneous injections of a minimum therapeutic dose of gonadotropin-releasing hormone agonist in a deposit formulation once per 28 days, with parallel application of “cover” therapy. Moreover, the injections of the gonadotropin-releasing hormone agonist are administered within 6 months, while as a "cover" therapy it is prescribed to administer orally Abyufen for 5-10 days three times a day at a dose 400 mg, Tivortin for 14 days three times a day at a dose of 1 g and a calcium and vitamin D3-based drug for 14 days at a dose of 1500 mg of calcium and 600 IU of vitamin D3; after a two-week break, the course of therapy "cover" is repeated.
UAU201404815U2014-05-052014-05-05Method for treating adenomyosis in women
UA94010U
(en)